forty patients with metastatic breast cancer who had received no previous cytotoxic therapy were treated with a combination chemotherapy program cmf ( p ) , which included methotrexate , 60 mg/m2 , and 5-fluorouracil , 700 mg/m2 intravenously on the first and eighth days , in addition to cyclophosphamide , 100 mg/m2 , and prednisone , 40 mg/m2 , by mouth daily from the first to the fourteenth day of a 28-day cycle .
C0950521
cmf
C0016360
5-fluorouracil